Beacon Medical Interchange

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Beacon Medical Interchange

beaconmedic.com

Lung
Testicular
Prostate
Renal Cell
Bladder
Gastrointestinal
General

Playback speed

10 seconds

Dacomitinib: Dark Horse EGFR TKI Charges into First Line Setting for Advanced NSCLC

By Beacon Medical Interchange FEATURING Jack West

0 views

November 2, 2018

Dr. Jack West reviews the results of the ARCHER-1050 trial that showed superior efficacy with ...
read more ↘ dacomitinib vs. gefitinib in EGFR mutation-positive NSCLC. Is it too little, too late for dacomitinib, or can it find a place in a crowded first line setting?
↖ read less

Comments 0